 Connection
Co-Authors
This is a "connection" page, showing publications co-authored by Jane Reusch and Kevin Josey.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.500 |
|
|
|
-
Josey KP, Liu W, Warsavage T, Medici M, Kvist K, Derington CG, Reusch JEB, Ghosh D, Raghavan S. Real-world cardiovascular effects of liraglutide: transportability analysis of the LEADER trial. medRxiv. 2025 May 30.
Score: 0.248
-
Raghavan S, Warsavage T, Liu WG, Raffle K, Josey K, Saxon DR, Phillips LS, Caplan L, Reusch JEB. Trends in Timing of and Glycemia at Initiation of Second-line Type 2 Diabetes Treatment in U.S. Adults. Diabetes Care. 2022 06 02; 45(6):1335-1345.
Score: 0.202
-
Edward JA, Josey K, Bahn G, Caplan L, Reusch JEB, Reaven P, Ghosh D, Raghavan S. Heterogeneous treatment effects of intensive glycemic control on major adverse cardiovascular events in the ACCORD and VADT trials: a machine-learning analysis. Cardiovasc Diabetol. 2022 04 27; 21(1):58.
Score: 0.050
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|